Flora Matrix IBS

2 billion CFU per capsule of the spore-forming bacterium Bacillus coagulans IS-2. Spore-forming bacteria such as Bacillus coagulans IS-2 are highly resistant to the harsh environments of the digestive tract and also demonstrate favorable antimicrobial actions and promote healthy digestion. Bacillus coagulans IS-2 has been shown to successfully treat IBS in children and adults, constipation, functional abdominal pain in children, and bacterial vaginosis in women receiving adjunctive antibiotic therapy. The relationship between bacteria, digestive function, and overall health is complex, to say the least. Although the last few decades of probiotic research have opened many new avenues for medical treatment, many questions remain regarding strain-specific properties and capabilities. Perhaps one problem with traditional probiotic species such as Lactobacillus acidophilus is poor survival through the harsh digestive system. Some species have a survival rate as low as 1 to 15% throughout the gastrointestinal tract. For this reason, some researchers have focused on spore-forming probiotic bacteria such as Bacillus coagulans. Bacillus coagulans and other spore-forming probiotics naturally enter a protective dormant spore phase during their life cycle if their survival is threatened. In this spore form, the survival rate is greatly enhanced because it is extremely resistant to the harsh acidic environment of the stomach, temperature changes, and other potential hazards. Spores of Bacillus strains can survive for years in their dormant state, but if given the right stimulus, such as nutrient availability, they can quickly germinate. The appropriate setting for germination and activation appears to be in the small intestine, where sugars, amino acids, and purines are widely available. Of course, just having a probiotic survive is not enough. Once germinated and activated, the beneficial effects on the health of the digestive tract and the entire body are even greater. Bacillus coagulans can promote digestion, increase nutrient absorption, and reduce inflammation by producing a variety of enzymes and short-chain fatty acids. In addition, Bacillus coagulans provides a natural antimicrobial effect by competing for resources and preventing the growth of pathogenic bacteria. It does this by creating an anaerobic and acidic environment in the intestines, making it inhospitable to various pathogens and providing ideal conditions for the proliferation of beneficial bacteria, such as lactobacilli and bifidobacteria species. Some research has even shown that Bacillus coagulans species can secrete bacteriocin, a well-known antibacterial compound, and can prevent dysbiosis and related diseases associated with antibiotic use. Overall, Bacillus coagulans helps promote a favorable gut flora by improving the diversity, composition, and metabolic function of the microbiota. Clinical studies have shown that Bacillus coagulans IS-2 strain is effective in treating irritable bowel syndrome (IBS) in children and adults, constipation, functional abdominal pain in children, and bacterial vaginosis in women receiving adjunctive antibiotic therapy. Flora-Matrix IBS provides 2 billion CFU per capsule of the resilient spore-forming bacteria strain, Bacillus coagulans IS-2. Flora-Matrix IBS is designed to support bowel regularity, manage the symptoms of irritable bowel syndrome, promote a healthy gut flora, and promote a healthy vaginal flora in women. Available in blister packs containing 60 vegetarian capsules per pack. Flora-Matrix IBS is shelf-stable and free from gluten, soy, and dairy. Flora-Matrix IBS belongs to the Flora-Matrix family of probiotics, each containing specialized strains for targeted results. Each Flora-Matrix probiotic contains unique strains with distinct activity and health benefits. These strains are individually selected and well-studied at validated dosages, ensuring targeted clinical results without the need for excessive colony-forming units.